| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.3B | $12.5B | $11.2B | $8.3B | $1.9B | $1.7B | $1.5B | $1.6B |
| Cost of Revenue | $4.6B | $4.1B | $3.8B | $2.2B | $2.1B | $1.8B | $1.7B | $1.7B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.4B | $3.2B | $3.4B | $1.7B | $1.5B | $1.5B | $1.6B | $1.6B |
| Operating Income | $6.5B | $4.0B | $4.9B | $4.2B | $0.7B | $0.8B | $0.7B | $0.6B |
| Net Income | $4.5B | $2.6B | $3.2B | $3.0B | $0.5B | $0.5B | $0.5B | $0.3B |
| EPS (Basic) | $14.67 | $8.25 | $10.25 | $12.56 | $1.89 | $2.22 | $2.06 | $1.03 |
| EPS (Diluted) | $14.66 | $8.23 | $10.20 | $12.51 | $1.88 | $2.20 | $2.03 | $1.02 |
| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $61.2B | $60.6B | $61.8B | $15.0B | $12.5B | $11.3B | $9.5B | $9.4B |
| Current Assets | $6.3B | $5.1B | $5.7B | $8.8B | $6.0B | $4.7B | $3.6B | $4.3B |
| Cash & Equivalents | $1.7B | $1.3B | $1.3B | $6.5B | $4.1B | $2.9B | $1.9B | $2.8B |
| Total Liabilities | $25.0B | $22.5B | $22.0B | $9.5B | $9.2B | $8.5B | $7.2B | $7.3B |
| Current Liabilities | $7.6B | $6.1B | $6.0B | $3.8B | $3.6B | $3.1B | $2.6B | $3.2B |
| Stockholders' Equity | $31.1B | $34.2B | $36.4B | $2.0B | $0.5B | $0.5B | $0.6B | $0.7B |
| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.7B | $3.7B | $2.6B | $3.6B | $3.6B | $2.8B | $2.1B | $2.0B |
| Investing Cash Flow | $-0.7B | $0.6B | $3.6B | $-0.1B | $-0.2B | $-0.1B | $-0.5B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-4.9B | $-4.3B | $-11.3B | $-1.0B | $-2.2B | $-1.8B | $-2.3B | $-1.5B |